Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Detalhes bibliográficos
Autor(a) principal: Dejnirattisai, Wanwisa
Data de Publicação: 2021
Outros Autores: Huo, Jiandong, Zhou, Daming, Zahradník, Jiří, Supasa, Piyada, Liu, Chang, Duyvesteyn, Helen M. E., Ginn, Helen M., Mentzer, Alexander J., Tuekprakhon, Aekkachai, Nutalai, Rungtiwa, Wang, Beibei, Dijokaite, Aiste, Khan, Suman, Avinoam, Ori, Bahar, Mohammad, Skelly, Donal, Adele, Sandra, Johnson, Sile Ann, Amini, Ali, Ritter, Thomas, Mason, Chris, Dold, Christina, Pan, Daniel, Assadi, Sara, Bellass, Adam, Omo-Dare, Nikki, Koeckerling, David, Flaxman, Amy, Jenkin, Daniel, Aley, Parvinder K., Voysey, Merryn, Clemens, Sue Ann Costa, Naveca, Felipe Gomes, Nascimento, Valdinete, Nascimento, Fernanda, Costa, Cristiano Fernandes da, Resende, Paola Cristina, Pauvolid-Correa, Alex, Siqueira, Marilda Agudo Mendonça Teixeira de, Baillie, Vicky, Serafin, Natali, Ditse, Zanele, Silva, Kelly da, Madhi, Shabir, Nunes, Marta C., Malik, Tariq, Openshaw, Peter J. M., Baillie, J. Kenneth, Semple, Malcolm G., Townsend, Alain R., Huang, Kuan-Ying A., Tan, Tiong Kit, Carroll, Miles W., Klenerman, Paul, Barnes, Eleanor, Dunachie, Susanna J., Constantinides, Bede, Webster, Hermione, Crook, Derrick, Pollard, Andrew J., Lambe, Teresa, Paterson, Neil G., Williams, Mark A., Hall, David R., Fry, Elizabeth E., Mongkolsapaya, Juthathip, Ren, Jingshan, Schreiber, Gideon, Stuart, David I., Screaton, Gavin R.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/50615
Resumo: Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
id CRUZ_8cf0fe27fa25a5eb8722c4694b3835d8
oai_identifier_str oai:www.arca.fiocruz.br:icict/50615
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Dejnirattisai, WanwisaHuo, JiandongZhou, DamingZahradník, JiříSupasa, PiyadaLiu, ChangDuyvesteyn, Helen M. E.Ginn, Helen M.Mentzer, Alexander J.Tuekprakhon, AekkachaiNutalai, RungtiwaWang, BeibeiDijokaite, AisteKhan, SumanAvinoam, OriBahar, MohammadSkelly, DonalAdele, SandraJohnson, Sile AnnAmini, AliRitter, ThomasMason, ChrisDold, ChristinaPan, DanielAssadi, SaraBellass, AdamOmo-Dare, NikkiKoeckerling, DavidFlaxman, AmyJenkin, DanielAley, Parvinder K.Voysey, MerrynClemens, Sue Ann CostaNaveca, Felipe GomesNascimento, ValdineteNascimento, FernandaCosta, Cristiano Fernandes daResende, Paola CristinaPauvolid-Correa, AlexSiqueira, Marilda Agudo Mendonça Teixeira deBaillie, VickySerafin, NataliDitse, ZaneleSilva, Kelly daMadhi, ShabirNunes, Marta C.Malik, TariqOpenshaw, Peter J. M.Baillie, J. KennethSemple, Malcolm G.Townsend, Alain R.Huang, Kuan-Ying A.Tan, Tiong KitCarroll, Miles W.Klenerman, PaulBarnes, EleanorDunachie, Susanna J.Constantinides, BedeWebster, HermioneCrook, DerrickPollard, Andrew J.Lambe, TeresaPaterson, Neil G.Williams, Mark A.Hall, David R.Fry, Elizabeth E.Mongkolsapaya, JuthathipRen, JingshanSchreiber, GideonStuart, David I.Screaton, Gavin R.2022-01-04T19:35:13Z2022-01-04T19:35:13Z2021DEJNIRATTISAI, Wanwisa et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. bioRxiv, p. 1-64, Dec. 2021.https://www.arca.fiocruz.br/handle/icict/5061510.1101/2021.12.03.471045engbioRxiv preprintOmicronSARS CoV-2África do SulMutaçõesOmicronSARS CoV-2Southern AfricaMutations in Spike (S)Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK / Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK / . Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK / Oxford University Hospitals NHS Foundation Trust, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.Oxford University Hospitals NHS Foundation Trust, Oxford, UK / Peter Medawar Building for Pathogen Research, Oxford, UK / Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.Oxford University Hospitals NHS Foundation Trust, Oxford, UK.Oxford University Hospitals NHS Foundation Trust, Oxford, UK.NIHR Oxford Biomedical Research Centre, Oxford, UK / Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust / Department of Respiratory Sciences, University of Leicester.Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust.Medical Sciences Division, University of Oxford.Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.Institute of Global Health, University of Siena, Siena, Brazil; Department of Paediatrics, University of Oxford, Oxford, UK.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Laboratório de Ecologia de Doenças Transmissíveis na Amazônia. Manaus, AM, Brasil.Fundação de Vigilância em Saúde do Amazonas. Manaus, AM, Brasil,Fundação Oswaldo Cruz, Instituto Oswaldo Cruz. Laboratorio de Vírus respiratórios. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz, Instituto Oswaldo Cruz. Laboratorio de Vírus respiratórios. Rio de Janeiro, RJ, Brasil / Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.Fundação Oswaldo Cruz, Instituto Oswaldo Cruz. Laboratorio de Vírus respiratórios. Rio de Janeiro, RJ, Brasil.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa / Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.National Infection Service, Public Health England (PHE), Porton Down, Salisbury, UK.National Heart & Lung Institute, Imperial College London.Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK.NIHR Health Protection Research Unit, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK / MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, Taiwan.MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK..Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK / National Infection Service, Public Health England (PHE), Porton Down, Salisbury, UK.Oxford University Hospitals NHS Foundation Trust, Oxford, UK / Peter Medawar Building for Pathogen Research, Oxford, UK / Translational Gastroenterology Unit, University of Oxford, Oxford, UK / NIHR Oxford Biomedical Research Centre, Oxford, UK.Oxford University Hospitals NHS Foundation Trust, Oxford, UK / Peter Medawar Building for Pathogen Research, Oxford, UK / Centre For Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK / Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand, Department of Medicine, University of Oxford, Oxford, UK.Nuffield Department of Medicine, University of Oxford, Oxford, UK.Nuffield Department of Medicine, University of Oxford, Oxford, UK.Nuffield Department of Medicine, University of Oxford, Oxford, UK.NIHR Oxford Biomedical Research Centre, Oxford, UK / Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK / Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.OPTIC consortium&ISARIC4C consortium$Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK / Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK / Siriraj Center of Research Excellence in Dengue & Emerging Pathogens, Dean Office for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, .Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK / Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK / Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK / Instruct-ERIC, Oxford House, Parkway Court, John Smith Drive, Oxford, UK.Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK / Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.On the 24th November 2021 the sequence of a new SARS CoV-2 viral isolate spreading rapidly in Southern Africa was announced, containing far more mutations in Spike (S) than previously reported variants. Neutralization titres of Omicron by sera from vaccinees and convalescent subjects infected with early pandemic as well as Alpha, Beta, Gamma, Delta are substantially reduced or fail to neutralize. Titres against Omicron are boosted by third vaccine doses and are high in cases both vaccinated and infected by Delta. Mutations in Omicron knock out or substantially reduce neutralization by most of a large panel of potent monoclonal antibodies and antibodies under commercial development. Omicron S has structural changes from earlier viruses, combining mutations conferring tight binding to ACE2 to unleash evolution driven by immune escape, leading to a large number of mutations in the ACE2 binding site which rebalance receptor affinity to that of early pandemic viruses.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83134https://www.arca.fiocruz.br/bitstream/icict/50615/1/license.txt0ab46789d568c4ba27c7b5d29a9fe9c4MD51ORIGINALDejnirattisai_Wanwisa_etal_IOC_COVID-19_2021_PREPRINT.pdfDejnirattisai_Wanwisa_etal_IOC_COVID-19_2021_PREPRINT.pdfapplication/pdf11884208https://www.arca.fiocruz.br/bitstream/icict/50615/2/Dejnirattisai_Wanwisa_etal_IOC_COVID-19_2021_PREPRINT.pdf1d414971dc4e77cb58226f44f76b8be6MD52icict/506152022-03-23 09:37:04.376oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-03-23T12:37:04Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
title Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
spellingShingle Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai, Wanwisa
Omicron
SARS CoV-2
África do Sul
Mutações
Omicron
SARS CoV-2
Southern Africa
Mutations in Spike (S)
title_short Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
title_full Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
title_fullStr Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
title_full_unstemmed Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
title_sort Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
author Dejnirattisai, Wanwisa
author_facet Dejnirattisai, Wanwisa
Huo, Jiandong
Zhou, Daming
Zahradník, Jiří
Supasa, Piyada
Liu, Chang
Duyvesteyn, Helen M. E.
Ginn, Helen M.
Mentzer, Alexander J.
Tuekprakhon, Aekkachai
Nutalai, Rungtiwa
Wang, Beibei
Dijokaite, Aiste
Khan, Suman
Avinoam, Ori
Bahar, Mohammad
Skelly, Donal
Adele, Sandra
Johnson, Sile Ann
Amini, Ali
Ritter, Thomas
Mason, Chris
Dold, Christina
Pan, Daniel
Assadi, Sara
Bellass, Adam
Omo-Dare, Nikki
Koeckerling, David
Flaxman, Amy
Jenkin, Daniel
Aley, Parvinder K.
Voysey, Merryn
Clemens, Sue Ann Costa
Naveca, Felipe Gomes
Nascimento, Valdinete
Nascimento, Fernanda
Costa, Cristiano Fernandes da
Resende, Paola Cristina
Pauvolid-Correa, Alex
Siqueira, Marilda Agudo Mendonça Teixeira de
Baillie, Vicky
Serafin, Natali
Ditse, Zanele
Silva, Kelly da
Madhi, Shabir
Nunes, Marta C.
Malik, Tariq
Openshaw, Peter J. M.
Baillie, J. Kenneth
Semple, Malcolm G.
Townsend, Alain R.
Huang, Kuan-Ying A.
Tan, Tiong Kit
Carroll, Miles W.
Klenerman, Paul
Barnes, Eleanor
Dunachie, Susanna J.
Constantinides, Bede
Webster, Hermione
Crook, Derrick
Pollard, Andrew J.
Lambe, Teresa
Paterson, Neil G.
Williams, Mark A.
Hall, David R.
Fry, Elizabeth E.
Mongkolsapaya, Juthathip
Ren, Jingshan
Schreiber, Gideon
Stuart, David I.
Screaton, Gavin R.
author_role author
author2 Huo, Jiandong
Zhou, Daming
Zahradník, Jiří
Supasa, Piyada
Liu, Chang
Duyvesteyn, Helen M. E.
Ginn, Helen M.
Mentzer, Alexander J.
Tuekprakhon, Aekkachai
Nutalai, Rungtiwa
Wang, Beibei
Dijokaite, Aiste
Khan, Suman
Avinoam, Ori
Bahar, Mohammad
Skelly, Donal
Adele, Sandra
Johnson, Sile Ann
Amini, Ali
Ritter, Thomas
Mason, Chris
Dold, Christina
Pan, Daniel
Assadi, Sara
Bellass, Adam
Omo-Dare, Nikki
Koeckerling, David
Flaxman, Amy
Jenkin, Daniel
Aley, Parvinder K.
Voysey, Merryn
Clemens, Sue Ann Costa
Naveca, Felipe Gomes
Nascimento, Valdinete
Nascimento, Fernanda
Costa, Cristiano Fernandes da
Resende, Paola Cristina
Pauvolid-Correa, Alex
Siqueira, Marilda Agudo Mendonça Teixeira de
Baillie, Vicky
Serafin, Natali
Ditse, Zanele
Silva, Kelly da
Madhi, Shabir
Nunes, Marta C.
Malik, Tariq
Openshaw, Peter J. M.
Baillie, J. Kenneth
Semple, Malcolm G.
Townsend, Alain R.
Huang, Kuan-Ying A.
Tan, Tiong Kit
Carroll, Miles W.
Klenerman, Paul
Barnes, Eleanor
Dunachie, Susanna J.
Constantinides, Bede
Webster, Hermione
Crook, Derrick
Pollard, Andrew J.
Lambe, Teresa
Paterson, Neil G.
Williams, Mark A.
Hall, David R.
Fry, Elizabeth E.
Mongkolsapaya, Juthathip
Ren, Jingshan
Schreiber, Gideon
Stuart, David I.
Screaton, Gavin R.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dejnirattisai, Wanwisa
Huo, Jiandong
Zhou, Daming
Zahradník, Jiří
Supasa, Piyada
Liu, Chang
Duyvesteyn, Helen M. E.
Ginn, Helen M.
Mentzer, Alexander J.
Tuekprakhon, Aekkachai
Nutalai, Rungtiwa
Wang, Beibei
Dijokaite, Aiste
Khan, Suman
Avinoam, Ori
Bahar, Mohammad
Skelly, Donal
Adele, Sandra
Johnson, Sile Ann
Amini, Ali
Ritter, Thomas
Mason, Chris
Dold, Christina
Pan, Daniel
Assadi, Sara
Bellass, Adam
Omo-Dare, Nikki
Koeckerling, David
Flaxman, Amy
Jenkin, Daniel
Aley, Parvinder K.
Voysey, Merryn
Clemens, Sue Ann Costa
Naveca, Felipe Gomes
Nascimento, Valdinete
Nascimento, Fernanda
Costa, Cristiano Fernandes da
Resende, Paola Cristina
Pauvolid-Correa, Alex
Siqueira, Marilda Agudo Mendonça Teixeira de
Baillie, Vicky
Serafin, Natali
Ditse, Zanele
Silva, Kelly da
Madhi, Shabir
Nunes, Marta C.
Malik, Tariq
Openshaw, Peter J. M.
Baillie, J. Kenneth
Semple, Malcolm G.
Townsend, Alain R.
Huang, Kuan-Ying A.
Tan, Tiong Kit
Carroll, Miles W.
Klenerman, Paul
Barnes, Eleanor
Dunachie, Susanna J.
Constantinides, Bede
Webster, Hermione
Crook, Derrick
Pollard, Andrew J.
Lambe, Teresa
Paterson, Neil G.
Williams, Mark A.
Hall, David R.
Fry, Elizabeth E.
Mongkolsapaya, Juthathip
Ren, Jingshan
Schreiber, Gideon
Stuart, David I.
Screaton, Gavin R.
dc.subject.other.pt_BR.fl_str_mv Omicron
SARS CoV-2
África do Sul
Mutações
topic Omicron
SARS CoV-2
África do Sul
Mutações
Omicron
SARS CoV-2
Southern Africa
Mutations in Spike (S)
dc.subject.en.pt_BR.fl_str_mv Omicron
SARS CoV-2
Southern Africa
Mutations in Spike (S)
description Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
publishDate 2021
dc.date.issued.fl_str_mv 2021
dc.date.accessioned.fl_str_mv 2022-01-04T19:35:13Z
dc.date.available.fl_str_mv 2022-01-04T19:35:13Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv DEJNIRATTISAI, Wanwisa et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. bioRxiv, p. 1-64, Dec. 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/50615
dc.identifier.doi.pt_BR.fl_str_mv 10.1101/2021.12.03.471045
identifier_str_mv DEJNIRATTISAI, Wanwisa et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. bioRxiv, p. 1-64, Dec. 2021.
10.1101/2021.12.03.471045
url https://www.arca.fiocruz.br/handle/icict/50615
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv bioRxiv preprint
publisher.none.fl_str_mv bioRxiv preprint
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/50615/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/50615/2/Dejnirattisai_Wanwisa_etal_IOC_COVID-19_2021_PREPRINT.pdf
bitstream.checksum.fl_str_mv 0ab46789d568c4ba27c7b5d29a9fe9c4
1d414971dc4e77cb58226f44f76b8be6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009300759511040